Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion type Assertion NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_head.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion description "[XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_provenance.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion evidence source_evidence_literature NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_provenance.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion SIO_000772 20575039 NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_provenance.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion wasDerivedFrom befree-20140225 NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_provenance.
- NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_assertion wasGeneratedBy ECO_0000203 NP420992.RAVVmkrfmlPr_MtmLq1WtL8vMBfW0kMxvqieJyXBmxe8k130_provenance.